IMPLANTABLE DEVICE FOR GROWTH HORMONE DELIVERY

Growth hormone deficiency causes growth failure, abnormal body composition, poor bone density, and chronic diseases in various organs to children, and diminished muscle weight, bond density, physical exercise capacity, alone with psychological symptoms.

Currently, patients are recommended to inject growth hormone subcutaneously by themselves at 30 minutes before sleeping, for 5 to 7 days a week. Various syringe systems are developed for patient convenience and safety. However, the administration for kids still requires help of parents, and invasive nature of injection still poses as a threat to all users.

To satisfy the unmet needs, we are developing an implantable device that could deliver drugs in a pulsatile manner over months to years after a single implantation procedure.